SS
TNGX icon

Simplicity Solutions’s Tango Therapeutics TNGX Stock Holding History

Simplicity Solutions’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$267K Buy
+26,961
New +$234K 0.01% 874

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Simplicity Solutions's TNGX Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Tango Therapeutics (TNGX) in Q4 2023: 26,961 shares worth $267K. The stake represents 0.01% of the portfolio and ranks #874 among its holdings.

121 funds tracked by Wall St. Rank hold TNGX as of Q4 2023.

  • Simplicity Solutions held 26,961 shares of Tango Therapeutics worth $267K as of Q4 2023.
  • Tango Therapeutics was a new Simplicity Solutions position in Q4 2023.
  • Tango Therapeutics made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #874 holding.
  • 121 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.